Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rusi Chen

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Internal and Emergency Medicine|March 29, 2024
Prediction of cardiovascular risk in patients with hepatocellular carcinoma receiving anti-angiogenic drugs: lessons from sorafenibBernardo Stefanini, Francesco Tovoli, Franco Trevisani, et al.
IEEE Journal of Biomedical and Health Informatics|February 17, 2026
OnUVS: An Online Motion Transfer Framework with Content-Texture Decoupling for High-Fidelity Ultrasound Video SynthesisHan Zhou, Rusi Chen, Xin Yang, et al.
Medical Image Analysis|December 12, 2023
Segment anything model for medical images?Yuhao Huang, Xin Yang, Lian Liu, et al.
Radiology. Artificial Intelligence|June 18, 2025
Artificial Intelligence in Breast US Diagnosis and Report GenerationJian Wang, HongTian Tian, Xin Yang, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 21, 2024
Suboptimal outcomes of sorafenib as a second-line treatment after atezolizumab-bevacizumab for unresectable hepatocellular carcinomaFrancesco Tovoli, Dante Pio Pallotta, Caterina Vivaldi, et al.
Liver Cancer|June 26, 2025
Etiology of Hepatocellular Carcinoma May Influence the Pattern of Progression under Atezolizumab-BevacizumabBernardo Stefanini, Fabio Piscaglia, Fabio Marra, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Internal and Emergency Medicine|March 29, 2024
Prediction of cardiovascular risk in patients with hepatocellular carcinoma receiving anti-angiogenic drugs: lessons from sorafenibBernardo Stefanini, Francesco Tovoli, Franco Trevisani, et al.
IEEE Journal of Biomedical and Health Informatics|February 17, 2026
OnUVS: An Online Motion Transfer Framework with Content-Texture Decoupling for High-Fidelity Ultrasound Video SynthesisHan Zhou, Rusi Chen, Xin Yang, et al.
Medical Image Analysis|December 12, 2023
Segment anything model for medical images?Yuhao Huang, Xin Yang, Lian Liu, et al.
Radiology. Artificial Intelligence|June 18, 2025
Artificial Intelligence in Breast US Diagnosis and Report GenerationJian Wang, HongTian Tian, Xin Yang, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 21, 2024
Suboptimal outcomes of sorafenib as a second-line treatment after atezolizumab-bevacizumab for unresectable hepatocellular carcinomaFrancesco Tovoli, Dante Pio Pallotta, Caterina Vivaldi, et al.
Liver Cancer|June 26, 2025
Etiology of Hepatocellular Carcinoma May Influence the Pattern of Progression under Atezolizumab-BevacizumabBernardo Stefanini, Fabio Piscaglia, Fabio Marra, et al.
Pageof 2